S
Shaomi Zhu
Researcher at Chengdu University of Traditional Chinese Medicine
Publications - 21
Citations - 281
Shaomi Zhu is an academic researcher from Chengdu University of Traditional Chinese Medicine. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 11 publications receiving 36 citations.
Papers
More filters
Journal ArticleDOI
Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
Linjiang Song,Xian Chen,Ling Mi,Chi Liu,Shaomi Zhu,Tianlin Yang,Xiaohong Luo,Qinxiu Zhang,Hua Lu,Xin Liang +9 more
TL;DR: Results showed that icariin could effectively trigger apoptosis and inhibit the migration of breast cancer cells via the SIRT6/NF‐κB signaling pathway, suggesting that icARIin might serve as a potential candidate drug for the treatment of Breast cancer.
Journal ArticleDOI
Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway.
TL;DR: It is demonstrated that CGA improved antitumor immunity, exerting antitumors and anti-metastatic effects by impairing the NF-κB/EMT signaling pathway, suggesting that C GA may serve as a potential candidate for therapy of breast cancer.
Journal ArticleDOI
The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
Mingxuan Chi,Kuai Ma,Jing Wang,Zhaolun Ding,Yunlong Li,Shaomi Zhu,Xin Liang,Qinxiu Zhang,Linjiang Song,Chi Liu,Chi Liu +10 more
TL;DR: The role of the human gut microbiota in the development and progression of several renal diseases, such as lupus nephritis, chronic kidney disease, diabetic nephropathy, and renal ischemia-reperfusion injury was discussed in this article.
Journal ArticleDOI
Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives
TL;DR: In this paper, the authors highlight regulatory mechanisms for lncRNAs in aerobic glycolysis that provide novel insights into cancer development and provide new strategies for clinical cancer management.
Journal ArticleDOI
Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo.
TL;DR: BA effectively triggered apoptosis, inhibited metastasis, and enhanced chemosensitivity of BC, implying that BA might serve as a promising agent for the treatment of BC.